Location
United States, North America
Cheque size
$1M - $75M
Investment Stage
Series A
Focus Areas
AI
Health IT
Health & Hospital Services
BioTech
Medical Devices
About Investor
Geoffrey C. Hsu is a General Partner at OrbiMed, where he helps lead the public equity team’s biotech and emerging markets efforts. He joined the firm in 2002 and has been a portfolio manager since 2005. Before OrbiMed, Hsu worked as a financial analyst in the healthcare investment banking group at Lehman Brothers. He also serves as portfolio manager for The Biotech Growth Trust, adding a public-markets lens to his biotech investing work.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,AL
Alicia Lenis
Canada, North America
$500K - $2M
Pre Seed
,Seed
,NP
Neil Peet
Canada, North America
$500K - $2M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.